To include your compound in the COVID-19 Resource Center, submit it here.

Spero raises $77M in IPO

Spero Therapeutics Inc. (NASDAQ:SPRO) sank 18% on its first day of trading Nov. 2 after raising $77 million on Nov. 1

Read the full 214 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE